Nanoform small is powerful logo Nanoform small is powerful logo
  • Contact Us
  • About Nanoform
    About Nanoform
    • Vision, mission and values
    • Organization
      Board of Directors
      CEO and Management Team
    • Success stories
    • Corporate Responsibility
  • Technology
    Technology
    • CESS®
      STARMAP®
    • Biologics
      Formulations
    • Case studies
  • Services
    Services
    • GMP Manufacturing
  • Corporate Governance
    Corporate Governance
    • Corporate Governance Statements
      General meeting
      Annual General Meeting 2022
      General meetings
    • The Board of Directors
      Board of Directors
      Duties of the Board of Directors
      Authorisations
      Board committees
      Remuneration of the Board
    • CEO and Management Team
      Remuneration
      Audit
      Internal Control and Risk Management
      Code of conduct
    • Articles of Association
      Insider administration
      Disclosure policy
      Transcations of managers
  • Investors
    Investors Investerare Sijoittajat
    • Financial Reports and Presentations
      Press releases
      Subscribe
    • Share and shareholders
      Share information
      Share capital development
      Certified Adviser
      Analyst Coverage
      Ownership structure
      Notifications of major shareholdings
      Manager Transactions
    • IPO 2020
    • Investor calendar
      Contact
    • Finansiella rapporter och presentationer
      Pressmeddelanden
      Prenumerera
    • Aktien och aktieägare
      Aktieinformation
      Aktiekapitalets utveckling
      Certified Adviser
      Analytiker
      Ägarstruktur
      Anmälan om betydande aktieägare
      Transaktioner utförda av personer i ledande ställning
    • Börsnotering
    • Investerarkalender
      Kontakt
    • Taloudelliset raportit ja esitykset
      Tiedotteet
      Tilaaminen
    • Osake ja osakkeeomistajat
      Tiedot osakkeesta
      Osakepääoman kehitys
      Hyväksytty neuvonantaja
      Analyytikot
      Omistusrakenne
      Ilmoitukset merkittävistä osakkeenomistajista
      Johtohenkilöiden liiketoimet
    • Listautuminen
    • Sijoittajakalenteri
      Yhteystiedot
  • Media
    Media
    • Press releases
      News
    • Pharmaceutical events
      Articles & videos
    • Subscribe
      Brochure
    • Contact
  • Careers
  • Contact

News

2022
  • 2021
  • 2020
  • 2019
  • 2018
  • All years
Non Regulatory
September 26, 2022

Nanoform unveils new patient statue

nanoform-1
Non Regulatory
July 14, 2022

Nanoform and Pharmanovia to breathe new life into iconic medicines

nanoform-6
Non Regulatory
May 4, 2022

Nanoform launches “STARMAP[®] Online” placing AI-power at the fingertips of medicine developers

Non Regulatory
March 11, 2022

Nanoform triples its GMP capacity and adds high potent handling (OEL <30 ng/m3) capabilities to its Helsinki facility to meet increasing demand.

Non Regulatory
February 4, 2022

Nanoform signs GMP manufacturing program with TargTex following formulation success

nanoform-4
Non Regulatory
November 17, 2021

Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021

Non Regulatory
November 12, 2021

Nanoform receives ISO/IEC 27001:2013 certification for its Information Security Management System

Non Regulatory
October 25, 2021

Nanoform’s trailblazing progress earns recognition from prestigious industry awards

nanoform-3
Non Regulatory
September 29, 2021

Nanoform receives funding to solve challenges for global health

nanoform-2
Non Regulatory
September 9, 2021

Nanoform technology delivers successful results for Herantis CDNF drug candidate

nanoform-5
Non Regulatory
August 3, 2021

Nanoform and Boehringer Ingelheim execute master services agreement

Non Regulatory
May 25, 2021

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

Non Regulatory
May 18, 2021

Nanoform’s final clinical results confirm value proposition to the pharma industry

Non Regulatory
April 21, 2021

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

Non Regulatory
March 31, 2021

Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept (“PoC”) Agreement for Two Ophthalmic Drug Candidates

Non Regulatory
March 22, 2021

Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Non Regulatory
February 9, 2021

Nanoform and Herantis sign Biologics Proof of Concept Agreement

Non Regulatory
January 11, 2021

Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)

Non Regulatory
December 23, 2020

Nanoform included in Nasdaq First North 25 index as of Jan 4th, 2021

Non Regulatory
December 22, 2020

Nanoform welcomed as a new member of Pharma Industry Finland (PIF)

Non Regulatory
December 2, 2020

Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)

Non Regulatory
October 26, 2020

Amplifying Scientific Innovation Podcast

Non Regulatory
September 1, 2020

Nanoform expands global commercial team with US appointments

Non Regulatory
July 9, 2020

Nanoform’s positive commercial momentum continues

Non Regulatory
June 15, 2020

Nanoform Finland Plc appoints Peter Hänninen as General Counsel

Non Regulatory
May 4, 2020

Nanoform awarded GMP certification

Non Regulatory
April 9, 2020

Nanoform appoints Miguel Calado as Chairman of the Board

Non Regulatory
March 23, 2020

A message from Nanoform regarding COVID-19

Non Regulatory
March 9, 2020

Nanoform and Orion collaborate on next-generation drug development

Non Regulatory
February 10, 2020

Nanoform establishes US subsidiary

Non Regulatory
December 20, 2019

Nanoform files for GMP certification

Non Regulatory
November 6, 2019

Nanoform wins the CPhI Excellence in Pharma Award for Formulation

Non Regulatory
October 10, 2019

Nanoform nominated for CPhI Award!

Non Regulatory
September 25, 2019

Nanoform and AstraZeneca Initiate Technology Evaluation

Non Regulatory
September 10, 2019

Nanoform strengthens board with appointment of Mads Laustsen

Non Regulatory
September 3, 2019

Nanoform appoints Mike Rea as Strategic Innovation Advisor

Non Regulatory
July 10, 2019

Nanoform appoints Director of Investor Relations following international growth

Non Regulatory
July 3, 2019

Nanoform continues strategic growth with €10 million private placement

Non Regulatory
June 27, 2019

Nanoform announces major rebrand

Non Regulatory
May 30, 2019

Our CCO, Christian Jones, interviewed at EBD Group’s BIO-Europe Spring 2019.

Non Regulatory
May 28, 2019

Nanoform accelerates growth with Director of Project Management appointment

European-Commission-award
Non Regulatory
May 28, 2019

Nanoform awarded with a Seal of Excellence from the European Commission

Non Regulatory
April 29, 2019

Nanoform strengthens GMP capabilities with Head of Manufacturing appointment

Non Regulatory
April 2, 2019

Nanoform strengthens board with appointment of Vice Chairman

Non Regulatory
March 5, 2019

Construction of Nanoform’s GMP manufacturing plant rapidly progresses

Non Regulatory
February 22, 2019

Contract Pharma

Non Regulatory
January 28, 2019

Nanoform signs world-leading sparse data AI expert

Non Regulatory
January 14, 2019

Nanoform set to boost world-class nanonization services with appointment of Chief Technology Officer

Non Regulatory
January 7, 2019

Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment

Non Regulatory
December 10, 2018

Nanoform continues rapid expansion with construction of GMP manufacturing plant

Non Regulatory
October 29, 2018

Nanoform set to globalize its technology with appointment of a Chief Commercial Officer

Non Regulatory
September 19, 2018

Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology

Contact us

+358 29 370 0150
info@nanoform.com

  • Privacy notice
  • Cookies

Subscribe

Read more about our protection of your personal data.

Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
FI-00790 Helsinki
Finland
Company number: 2730572-8